Product
Cetuximab + FOLFIRI
1 clinical trial
1 indication
Indication
Colorectal CancerClinical trial
A Phase III, Randomized, Two-armed, Parallel, Double-blind, Active-controlled, Equivalency Clinical Trial of Cetuximab (CinnaGen Co.) Efficacy and Safety Compared With Erbitux (Merck Co.) and FOLFIRI for RAS Wild-type mCRCStatus: Recruiting, Estimated PCD: 2025-11-30